The Pricing Integrity Problem
The Brief — Vol.I No.5
Why discounting is quietly undermining your clinic's positioning — and what to do instead
It begins, usually, with a quiet month.
Bookings are down. The forward schedule looks thin. Someone on the team suggests a promotion — a percentage off a popular treatment, a limited-time package, a flash sale pushed through the email list. It works. The diary fills. The month closes respectably. Nobody mentions it again.
The following year, the quiet month arrives again. The promotion works again. And slowly, without any single decision being made, the clinic has established a pattern. Certain patients have learned to wait. The standard price has become, in the market's understanding, a negotiating position. The clinic is working harder, discounting more frequently, and finding that each promotion produces a slightly smaller response than the last.
This is not a cash flow problem. It is a pricing integrity problem. And the research that describes what is actually happening — and why it is so difficult to reverse — is more instructive than most clinic owners realise.
What price actually communicates
In most categories of goods and services, price functions as a cost signal — it tells the buyer what they will have to give up in order to acquire the thing. In categories where the buyer cannot independently assess quality before purchase, price functions as something else entirely: a quality signal. It tells the buyer what kind of thing this is.
The economist Thorstein Veblen identified this mechanism in 1899, and over a century of subsequent research in consumer psychology and behavioural economics has refined the picture considerably.¹ In credence goods — services whose quality cannot be fully assessed even after consumption, which describes aesthetic medicine precisely — price is one of the strongest available proxies for quality in the minds of prospective buyers. A higher price does not merely mean the service costs more. It means, in the buyer's inference, that the service is worth more.
The implication of this for discounting is direct and uncomfortable. When a clinic reduces its price — through a promotion, a package deal, a platform offer, or an informal discount to a wavering patient — it is not merely accepting less revenue for a given treatment. It is communicating to every patient who encounters that reduced price that the standard price was, at some level, arbitrary. If the treatment was worth $X before the promotion, and it is now worth $X minus 30 percent, the patient's rational question is: which price reflects the actual value? The answer they tend to arrive at is the lower one.
McKinsey's research into pricing integrity across professional services finds that businesses which discount reactively — in response to demand fluctuations rather than as a designed strategic choice — experience a measurable and compounding erosion of their price position over time, independent of the actual quality of their service.² The discounting does not merely affect the promoted period. It recalibrates the market's understanding of what the service is worth.
The patient who has learned to wait
The most concrete consequence of reactive discounting in aesthetic medicine is the development of what behavioural economists call a promotional dependency in the patient base.
Patients are rational. When a clinic establishes a pattern of periodic discounting — even informally, even irregularly — a portion of the patient base will observe that pattern and adjust their behaviour accordingly. They will defer booking until a promotion is announced. They will ask, directly or indirectly, whether a discount is available. They will recommend the clinic to friends with the caveat that the best time to book is during a promotion. This behaviour is not disloyalty. It is a learned response to a signal the clinic has been sending repeatedly.
Bain & Company's customer loyalty research documents this dynamic across service industries: once a promotional dependency is established in a customer base, reversing it requires a sustained period — typically 12 to 18 months — of consistent full-price positioning, during which some price-sensitive patients will leave.³ The alternative is to continue the cycle, accepting progressively lower margins and a patient base increasingly segmented toward price sensitivity rather than value alignment.
Neither outcome is attractive. But the first leads somewhere better than the second.
The platform problem
Promotional dependency in the patient base is one consequence of reactive discounting. The distribution problem created by third-party deal platforms is another, and in some respects a more structurally damaging one.
Group-buying sites, daily deal platforms, and discount aggregators operate on a straightforward commercial logic: they drive volume through price reduction and take a margin from the transaction. For a clinic with spare capacity and no established positioning, this can appear to solve two problems simultaneously. It fills appointments. It generates new patient exposure.
What it also does — and what the platform's commercial framing does not surface — is permanently associate the clinic's brand with a price point that is inconsistent with its intended positioning. A patient who books their first appointment through a discount aggregator arrives with a price-comparison frame of reference. They have found this clinic the same way they find a hotel room or a flight: by filtering on price among comparable options. The positioning work the clinic has done on its website, in its consultation, in its communications — all of it is now operating against the frame established by the channel through which this patient arrived.
Think with Google's research on consumer decision-making in healthcare finds that the context in which a patient first encounters a provider shapes their subsequent evaluation of that provider more durably than the provider's own communications.⁴ The clinic that appears on a discount aggregator is not merely accepting a lower price for that transaction. It is accepting the frame that platform imposes on every interaction that follows.
What the luxury sector teaches about price protection
The brands that have most successfully protected their price position over time — Hermès, Chanel, certain premium skincare houses — share a structural commitment that runs counter to most short-term commercial thinking: they treat price stability as a brand asset, not merely as a margin target.
Hermès does not discount. Not during economic downturns, not during slow seasons, not through third-party channels. The consistency of this position is itself a communication — it tells the market, repeatedly and credibly, that the price reflects something real and stable about what is being offered. When Hermès raises prices, as it does periodically, the market interprets this not as opportunism but as confirmation of the brand's confidence in its own value.⁵
The lesson for aesthetic clinics is not that discounting is morally wrong or that promotions should never exist. It is that the design of any offer matters as much as the offer itself. There is a meaningful difference between a discount that signals desperation and a gesture of value that signals generosity. The clinic that offers an established patient early access to a new treatment, or that acknowledges a significant milestone in a relationship in a way that has personal meaning, is offering value without communicating that its standard price was wrong. The patient feels recognised rather than bargained with.
Designing value without discounting
The alternative to reactive discounting is not rigidity. It is intentionality — the deliberate design of value that reinforces rather than undermines the price position.
Several approaches have strong support in the consumer psychology literature. Recognition-based loyalty — acknowledging patient milestones, remembering preferences, communicating that the individual relationship is valued — produces higher retention rates than transactional loyalty programmes while making no impact on price integrity.⁶ Access-based value — offering established patients early availability, priority scheduling, or information about new treatments before they are publicly announced — creates a sense of privilege without price reduction. Education-based value — providing genuinely useful information about treatment maintenance, skin health, or procedural planning as part of the ongoing patient relationship — positions the clinic as a trusted resource rather than a transaction provider.
None of these require reducing the price of a treatment. All of them require deliberate attention to the patient relationship as something worth designing and protecting.
Three things you can do this week
Three places to begin:
Audit your last twelve months of promotional activity. List every discount, promotion, package deal, or platform offer your clinic has run in the past year. For each one, identify what triggered it — was it a strategic decision, or a response to a quiet period? What was the measurable impact on booking volume in the two months following the promotion? And, most importantly, what did it communicate to the patients who saw it about the standard price of your services? That audit will tell you whether you have a promotional pattern and how established it has become.
Remove or decline to renew one price-compromising platform listing. If your clinic currently appears on a discount aggregator or group-buying platform, identify the one whose patient profile is least consistent with your intended positioning and do not renew it. Do not replace it with another promotion. Replace it with nothing, and observe what happens to enquiry quality — not just volume — over the following 90 days. In most cases, the patients who arrive without the deal frame are more aligned, more likely to return, and more economically valuable over a 12-month horizon than those who arrived because of the deal.
Design one piece of recognition-based value for established patients. Identify a group of patients who have attended three or more times in the past year. Write a communication — not a promotion, a communication — that acknowledges their relationship with the clinic in specific, personal terms, and offers them something that has genuine value without reducing a price. Early access to a new service, a complimentary review appointment, a piece of useful information relevant to their treatment history. Measure the response. It will almost certainly exceed the response rate of your last promotional email, at zero cost to your price position.
Pricing integrity is not about being expensive. It is about being consistent — about ensuring that every signal the clinic sends about its value is coherent with every other signal, and that the price a patient pays reflects something real and stable about what they are receiving.
The clinic that holds its price position through a quiet month — not through indifference to commercial pressure, but through the confidence that its value is genuine and its communication of that value is sufficient — is building something that a promotional calendar never can: a market position that compounds over time.
That confidence is earned through clarity. It is protected through consistency. And once established, it is one of the most durable competitive advantages available to an aesthetic practice.
References
EdelmVeblen, T. The Theory of the Leisure Class. Macmillan, 1899.
McKinsey & Company. Pricing to Win: How to Establish and Protect Price Integrity. McKinsey Insights, 2022–2023.
Bain & Company. Prescription for Cutting Costs: Loyal Relationships. Customer loyalty research, 2023.
Think with Google. Healthcare Decision-Making and Digital Touchpoints. 2021–2024.
Kapferer, J-N. & Bastien, V. The Luxury Strategy: Break the Rules of Marketing to Build Luxury Brands. 2nd ed. Kogan Page, 2012.
Cialdini, R. Influence: The Psychology of Persuasion. Harper Business, 2021 edition.
The Aesthetic Collective provides brand strategy, communications, and marketing services to aesthetic medicine clinics across Australia and New Zealand.